Trials / Withdrawn
WithdrawnNCT02970331
A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 12 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, open-label study that will evaluate the safety/tolerability and pharmacodynamics as well as the pharmacokinetic profile (sub-population analysis), in 50 evaluable adolescents 12 to \< 17 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pefcalcitol ointment, 0.005% | pefcalcitol ointment, 0.005% |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2016-11-22
- Last updated
- 2023-04-18
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02970331. Inclusion in this directory is not an endorsement.